FuKoichi, J., Kitamura, K., Kawahara, R., Shihoya, W., Nureki, O., Hosoya, S., Nakagawa, R., Mashima, T., Itoh, H., Inoue, M. and Sakurai, K. Photoaffinity labeling strategy reveals tetraspanin CD9 as a transient target of anticancer Yaku’amide B.
J. Am. Chem. Soc., in press (2026) |
Moroishi, K., Nakamoto, M., Fujita, S., Kawahara, M., Katayama, R. and Matsusaki, M. Escape from cell uptake: Drug-free cancer therapeutics regulated by hydrophobicity and negative charge.
Mater. Today Bio, 102752 (2025) |
Otsuka, M., Okamoto, Y., Hasebe, A., Shirahama, H. and Tomida, A. HER3 enhances ATF4 induction and survival in breast cancer cells during endoplasmic reticulum stress.
Biochem. Biophys. Res. Commun., 797, 153215 (2026) |
Yokomura, M., Nagano, S., Kawamoto, H., Hirohashi, Y., Torigoe, T., Asakage, T. and Katayama, R. Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity.
Cancer Immunol. Immunother., 75, 33 (2026) |
Wang, H., Yang, J., Katayama, R., Matusaki, M., Miyao, T., Li, Y. and Zhou, J. NuclSeg-v2.0: Nuclei segmentation using semi-supervised stain deconvolution with real-time user feedback.
Pattern Recognit, in press (2025) |
Wang, X., Shinjo, K., Kumegawa, K., Maruyama, R., Mii, S., Shiraki, Y., Nishimura, T., Murofushi, Y., Suzuki, M., Kabasawa, T., Futakuchi, M., Kanai, A., Suzuki, Y., Enomoto, A. and Kondo, Y. Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.
Br. J. Cancer, in press (2025) |
Toyohara, Y., Sone, K., Kumegawa, K., Yamamoto, Y., Hachijo, R., Kukita, A., Taguchi, A., Ikemura, M., Miyamoto, Y., Tanikawa, M., Iriyama, T., Mori, M., Hamamoto, R., Ushiku, T., Oda, K., Hirota, Y., Maruyama, R. and Osuga, Y. Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma.
BMC Cancer, 25, 1873 (2025) |
Sasaki, N., Homme, M. and Kitajima, S. Mapping the inflammatory origins of lung cancer.
Cancer Cell, in press (2025) |
Tenma, T., Yoshida, R., Yanada, H., Nitanai, K., Nagato, T., Oyama, K., Sasaki, N., Homme, M., Mori, C., Ohkuri, T., Ono, Y., Tange, S., Minami, Y., Kobayashi, H., Mizukami, Y., Barbie, D. A., Kitajima, S. and Sasaki, T. Dipeptidyl peptidase 4 restoration facilitates anti-tumor immunity in KRAS-LKB1-mutant lung cancer.
Cancer Res. Commun., in press (2025) |
Yoshido, A., Ishiguro, K., Kitajima, H., Niinuma, T., Kumegawa, K., Maezawa, M., Tsukahara, T., Toyota, M., Yorozu, A., Sasaki, H., Yamamoto, E., Kai, M., Idogawa, M., Torigoe, T., Nakase, H., Maruyama, R. and Suzuki, H. DOT1L inhibition exerts the anti-tumor effect by activating interferon signaling in breast cancer cells.
Clin. Epigenetics, 17, 201 (2025) |
